---
$id: https://graph.org.ai/products/commodity/51263110
$type: Product
source: UNSPSC
code: "51263110"
title: "Idropranolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Idropranolol

**UNSPSC Code**: 51263110
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5U6118QYHK, chemically known as 1-((5,6-dihydro-1-naphthyl)oxy)-3-(isopropylamino)-2-propanol but generally known as idropranolol, which bears US NIH Compound Identifier 163314. European Medicines Agency schedules Idropranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08122MIG. The term IDROPRANOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). IDROPRANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule idropranolol under HS 29221980 and SITC 51461. As of Q4 2014, IDROPRANOLOL remains the US FDA Preferred Term for this commodity. Idropranolol bears US NLM identifiers UMLS ID C2827192 and NCI Concept Code C83781. SMILES: O(CC(O)CNC(C)C)C1C2C(CCC=C2)CCC1.

